Business / Finance

RSS

Park Nicollet, HealthPartners complete merger

HealthPartners and Park Nicollet Health Services today announced the completion of their agreement to combine their organizations. Effective today, the two organizations are officially joined under the name HealthPartners and a single, consumer-governed board of directors.

1 Jan 2013

NHI purchases 120-unit assisted living and memory care facility in Wisconsin

National Health Investors, Inc. announced today a $20.2 million purchase of Charleston House, a 120-unit assisted living and memory care facility in Beaver Dam, Wisconsin.

26 Dec 2012

NanoViricides to advance influenza drug candidate with completed $5M funding

NanoViricides, Inc., announced today that it has received the final tranche of $2.5M from Seaside 88, LP, thereby completing the total of a $5M financing. This raise, and the receipt of the initial $2.5M tranche, was previously announced on June 29, 2012.

25 Dec 2012

MEDNAX acquires South Oakland Anesthesia Associates

MEDNAX, Inc., today announced the acquisition of South Oakland Anesthesia Associates, P.C., a physician group practice that provides anesthesia care and pain management services at three hospitals, four ambulatory surgery centers, one eye center, and four pain management centers throughout Oakland, Wayne and Macomb counties in Michigan.

21 Dec 2012

Acorda Therapeutics acquires Neuronex

Acorda Therapeutics, Inc. today announced that the Company has completed the acquisition of Neuronex, Inc., a privately held company developing a nasal spray formulation of diazepam. Under the terms of the agreement, Acorda paid $6.8 million to Neuronex to complete the acquisition.

21 Dec 2012

Akorbi announces aggressive growth strategy in early 2012

Akorbi, one of the health insurance industry's largest suppliers of translation and interpretation services, announced an aggressive growth strategy in early 2012 that included the addition of multilingual and technology consulting staffing services.

21 Dec 2012

Echo Therapeutics prices underwritten public offering of 3,200,000 shares of common stock

Echo Therapeutics, Inc., a company developing its needle-free Symphony tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring system, today announced the pricing of a previously announced underwritten public offering of 3,200,000 shares of its common stock, offered at a price to the public of $0.95 per share.

20 Dec 2012

Coherent announces acquisition of Lumera Laser

Coherent, Inc. today announced that it had acquired privately held Lumera Laser GmbH (Kaiserslautern, Germany) for approximately $52 million in an all cash transaction.

20 Dec 2012

Ortho Kinematics closes more than $2 million in Series B financing

Ortho Kinematics‚ Inc. (OKI), a privately held healthcare diagnostics company focused on spine imaging informatics, announced today the close of more than $2 million in its Series B financing.

18 Dec 2012

Marketplace changes: Hospitals work on insurance arms; Walgreen eyes hospice business

A growing number of hospital systems are moving to start their own insurance plans, aiming to broaden their roles and prepare for the changes coming under the federal health-care overhaul. Piedmont Healthcare and WellStar Health System, both in the Atlanta area, are set to announce a jointly owned insurance arm, with the goal of marketing coverage to employers and Medicare recipients in 2014.

18 Dec 2012

Allakos closes $32M Series A financing to develop antibody-based therapeutics

Allakos Inc. announced today that it has completed a $32 million Series A preferred stock financing led by Novo Ventures with participation from Alta Partners, RiverVest Venture Partners and the Roche Venture Fund. Peter Moldt , PhD., Partner at Novo Ventures, Robert Alexander , PhD., Director at Alta Partners and John McKearn PhD., Managing Director at RiverVest Venture Partners, will join the Board of Directors.

17 Dec 2012

Naurex announces completion of $38M Series B financing

Naurex Inc., a clinical-stage company developing innovative treatments to address unmet needs in psychiatry and neurology, today announced the completion of a $38 million Series B financing led by new investor Baxter Ventures.

17 Dec 2012

Patheon acquires Banner Pharmacaps

Patheon Inc., a leading provider of contract development and manufacturing services to the global pharmaceutical industry, today announced that it has completed its acquisition of Banner Pharmacaps, a specialty pharmaceutical business dedicated to the research, development and manufacturing of unique gelatin-based dosage forms.

15 Dec 2012

Sister Kenny Rehabilitation Institute and Courage Center announce merger agreement

In a bold move meant to advance the care and services provided to the disability community, Courage Center and Allina Health announced today that their boards of directors have approved a proposed merger between the Sister Kenny Rehabilitation Institute and Courage Center.

15 Dec 2012

Zimmer authorizes cash dividend to stockholders for fourth quarter 2012

Zimmer Holdings, Inc., a global leader in musculoskeletal care, today announced that its Board of Directors has authorized a cash dividend to stockholders for the fourth quarter of 2012.

14 Dec 2012

CEL-SCI net loss decreases to $17.6 million for fiscal year 2012

CEL-SCI Corporation reported financial results today for the fiscal year ended September 30, 2012.

14 Dec 2012

Dr. Reddy's Laboratories launches public offer to acquire OctoPlus shares

Dr. Reddy's Laboratories Limited, together with its subsidiaries, launches the recommended public offer to acquire all the issued and outstanding shares of OctoPlus N.V., a service-based specialty pharmaceutical company, at an offer price of EUR 0.52 (cum dividend) per share.

14 Dec 2012

Amgen declares $0.47 per share dividend for first quarter 2013

Amgen announced that its Board of Directors today declared a $0.47 per share dividend for the first quarter of 2013.

14 Dec 2012

Champions Oncology operating revenues increase to $3.6M for six months ended October 31, 2012

Champions Oncology, Inc. (OTC: CSBR), engaged in the development of advanced technology solutions and services to personalize the development and use of oncology drugs, announced today its financial results for the fiscal quarter ended October 31, 2012.

13 Dec 2012

Max Reinhardt named worldwide President of Depuy Synthes Spine

The DePuy Synthes Companies of Johnson & Johnson announced today that Max Reinhardt has been named Worldwide President of DePuy Synthes Spine, a global leader in spinal care. Mr. Reinhardt has been with the company since 2002, most recently as Vice President of Worldwide Marketing.

13 Dec 2012